• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

趋化因子诱饵受体 D6 可预防心肌梗死后过度炎症和不良心室重构。

The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.

机构信息

Université Paris Descartes, INSERM UMR-S970, Paris Cardiovascular Research Center, Hôpital Européen Georges Pompidou. Paris, France.

出版信息

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2206-13. doi: 10.1161/ATVBAHA.112.254409. Epub 2012 Jul 12.

DOI:10.1161/ATVBAHA.112.254409
PMID:22796582
Abstract

OBJECTIVE

Leukocyte infiltration in ischemic areas is a hallmark of myocardial infarction, and overwhelming infiltration of innate immune cells has been shown to promote adverse remodeling and cardiac rupture. Recruitment of inflammatory cells in the ischemic heart depends highly on the family of CC-chemokines and their receptors. Here, we hypothesized that the chemokine decoy receptor D6, which specifically binds and scavenges inflammatory CC-chemokines, might limit inflammation and adverse cardiac remodeling after infarction.

METHODS AND RESULTS

D6 was expressed in human and murine infarcted myocardium. In a murine model of myocardial infarction, D6 deficiency led to increased chemokine (C-C motif) ligand 2 and chemokine (C-C motif) ligand 3 levels in the ischemic heart. D6-deficient (D6(-/-)) infarcts displayed increased infiltration of pathogenic neutrophils and Ly6Chi monocytes, associated with strong matrix metalloproteinase-9 and matrix metalloproteinase-2 activities in the ischemic heart. D6(-/-) mice were cardiac rupture prone after myocardial infarction, and functional analysis revealed that D6(-/-) hearts had features of adverse remodeling with left ventricle dilation and reduced ejection fraction. Bone marrow chimera experiments showed that leukocyte-borne D6 had no role in this setting, and that leukocyte-specific chemokine (C-C motif) receptor 2 deficiency rescued the adverse phenotype observed in D6(-/-) mice.

CONCLUSIONS

We show for the first time that the chemokine decoy receptor D6 limits CC-chemokine-dependent pathogenic inflammation and is required for adequate cardiac remodeling after myocardial infarction.

摘要

目的

缺血区白细胞浸润是心肌梗死的一个标志,大量固有免疫细胞的浸润已被证明可促进不良重构和心脏破裂。缺血性心脏中炎症细胞的募集高度依赖于 CC 趋化因子家族及其受体。在这里,我们假设趋化因子诱饵受体 D6 特异性结合和清除炎症性 CC 趋化因子,可能限制梗塞后炎症和不良心脏重构。

方法和结果

D6 在人和鼠梗死心肌中表达。在心肌梗死的鼠模型中,D6 缺乏导致缺血心肌中趋化因子(C-C 基序)配体 2 和趋化因子(C-C 基序)配体 3 水平升高。D6 缺陷(D6(-/-))梗死显示缺血心肌中致病性中性粒细胞和 Ly6Chi 单核细胞浸润增加,与基质金属蛋白酶-9 和基质金属蛋白酶-2 活性增强相关。D6(-/-) 小鼠在心肌梗死后易发生心脏破裂,功能分析显示 D6(-/-) 心脏具有不良重构的特征,表现为左心室扩张和射血分数降低。骨髓嵌合体实验表明,白细胞携带的 D6 在这种情况下没有作用,并且白细胞特异性趋化因子(C-C 基序)受体 2 缺乏可挽救 D6(-/-) 小鼠观察到的不良表型。

结论

我们首次表明,趋化因子诱饵受体 D6 限制 CC 趋化因子依赖性致病性炎症,是心肌梗死后适当心脏重构所必需的。

相似文献

1
The chemokine decoy receptor D6 prevents excessive inflammation and adverse ventricular remodeling after myocardial infarction.趋化因子诱饵受体 D6 可预防心肌梗死后过度炎症和不良心室重构。
Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2206-13. doi: 10.1161/ATVBAHA.112.254409. Epub 2012 Jul 12.
2
Ly6C Monocytes Oscillate in the Heart During Homeostasis and After Myocardial Infarction-Brief Report.Ly6C单核细胞在稳态及心肌梗死后于心脏中呈振荡变化——简要报告
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1640-1645. doi: 10.1161/ATVBAHA.117.309259. Epub 2017 Jun 29.
3
Splenic Ly6C monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice.脾源性Ly6C单核细胞在血红素加氧酶-1缺陷小鼠缺血后晚期左心室不良重塑中起作用。
Basic Res Cardiol. 2017 Jul;112(4):39. doi: 10.1007/s00395-017-0629-y. Epub 2017 May 22.
4
CD8 T-cells negatively regulate inflammation post-myocardial infarction.CD8 T 细胞在心肌梗死后负向调节炎症。
Am J Physiol Heart Circ Physiol. 2019 Sep 1;317(3):H581-H596. doi: 10.1152/ajpheart.00112.2019. Epub 2019 Jul 19.
5
Toll-like receptor 7 deficiency promotes survival and reduces adverse left ventricular remodelling after myocardial infarction.Toll 样受体 7 缺陷可促进心肌梗死后的生存并减少不良的左心室重构。
Cardiovasc Res. 2019 Oct 1;115(12):1791-1803. doi: 10.1093/cvr/cvz057.
6
S100A9 Links Inflammation and Repair in Myocardial Infarction.S100A9 在心肌梗死中连接炎症与修复。
Circ Res. 2020 Aug 14;127(5):664-676. doi: 10.1161/CIRCRESAHA.120.315865. Epub 2020 May 21.
7
Monocytes prime autoreactive T cells after myocardial infarction.单核细胞在心肌梗死后使自身反应性 T 细胞致敏。
Am J Physiol Heart Circ Physiol. 2020 Jan 1;318(1):H116-H123. doi: 10.1152/ajpheart.00595.2019. Epub 2019 Dec 6.
8
Lgr4 Governs a Pro-Inflammatory Program in Macrophages to Antagonize Post-Infarction Cardiac Repair.Lgr4 调控巨噬细胞中的促炎程序以拮抗心肌梗死后的心脏修复。
Circ Res. 2020 Sep 25;127(8):953-973. doi: 10.1161/CIRCRESAHA.119.315807. Epub 2020 Jun 30.
9
β2-Adrenergic receptor-dependent chemokine receptor 2 expression regulates leukocyte recruitment to the heart following acute injury.β2-肾上腺素能受体依赖性趋化因子受体2的表达调节急性损伤后白细胞向心脏的募集。
Proc Natl Acad Sci U S A. 2016 Dec 27;113(52):15126-15131. doi: 10.1073/pnas.1611023114. Epub 2016 Dec 12.
10
Dysfunctional and Proinflammatory Regulatory T-Lymphocytes Are Essential for Adverse Cardiac Remodeling in Ischemic Cardiomyopathy.功能失调和促炎调节性 T 淋巴细胞是缺血性心肌病不良心脏重构所必需的。
Circulation. 2019 Jan 8;139(2):206-221. doi: 10.1161/CIRCULATIONAHA.118.036065.

引用本文的文献

1
Targeting Lactic Acid Modification in Ischemic Heart Diseases: Novel Therapeutics and Mechanism.靶向缺血性心脏病中的乳酸修饰:新型疗法与机制
J Cardiovasc Transl Res. 2025 Apr;18(2):257-267. doi: 10.1007/s12265-025-10593-3. Epub 2025 Feb 7.
2
Macrophage heterogeneity in myocardial infarction: Evolution and implications for diverse therapeutic approaches.心肌梗死中的巨噬细胞异质性:演变及其对多种治疗方法的影响
iScience. 2024 Jun 14;27(7):110274. doi: 10.1016/j.isci.2024.110274. eCollection 2024 Jul 19.
3
The atypical chemokine receptor 2 reduces T cell expansion and tertiary lymphoid tissue but does not limit autoimmune organ injury in lupus-prone B6lpr mice.
非典型趋化因子受体 2 可减少 T 细胞扩增和三级淋巴组织形成,但不能限制狼疮易感 B6.lpr 小鼠的自身免疫性器官损伤。
Front Immunol. 2024 May 10;15:1377913. doi: 10.3389/fimmu.2024.1377913. eCollection 2024.
4
Regenerative loss in the animal kingdom as viewed from the mouse digit tip and heart.从小鼠指尖和心脏看动物王国中的再生损失。
Dev Biol. 2024 Mar;507:44-63. doi: 10.1016/j.ydbio.2023.12.008. Epub 2023 Dec 24.
5
Macrophage-driven cardiac inflammation and healing: insights from homeostasis and myocardial infarction.巨噬细胞驱动的心脏炎症与修复:从稳态和心肌梗死中获得的认识。
Cell Mol Biol Lett. 2023 Oct 19;28(1):81. doi: 10.1186/s11658-023-00491-4.
6
Fractalkine/CXCR1 in Dilated Cardiomyopathy: A Potential Future Target for Immunomodulatory Therapy?扩张型心肌病中的趋化因子/ CXCR1:免疫调节治疗未来的潜在靶点?
Cells. 2023 Sep 28;12(19):2377. doi: 10.3390/cells12192377.
7
Prognostic role of tissue plasminogen activator in coronary artery disease with or without aortic valve sclerosis.组织型纤溶酶原激活物在合并或不合并主动脉瓣钙化的冠状动脉疾病中的预后作用。
ESC Heart Fail. 2023 Aug;10(4):2541-2549. doi: 10.1002/ehf2.14420. Epub 2023 Jun 12.
8
Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome.心肌梗死中的炎症:间充质干细胞及其分泌组的作用
Cell Death Discov. 2022 Nov 9;8(1):452. doi: 10.1038/s41420-022-01235-7.
9
The Role of Atypical Chemokine Receptor D6 (ACKR2) in Physiological and Pathological Conditions; Friend, Foe, or Both?非典型趋化因子受体 D6(ACKR2)在生理和病理条件下的作用;朋友、敌人,还是两者兼有?
Front Immunol. 2022 May 23;13:861931. doi: 10.3389/fimmu.2022.861931. eCollection 2022.
10
Intrapericardial Administration of Secretomes from Menstrual Blood-Derived Mesenchymal Stromal Cells: Effects on Immune-Related Genes in a Porcine Model of Myocardial Infarction.月经血源性间充质基质细胞分泌组的心包内给药:对猪心肌梗死模型中免疫相关基因的影响
Biomedicines. 2022 May 11;10(5):1117. doi: 10.3390/biomedicines10051117.